Elixinol Wellness Statistics
Total Valuation
ELLXF has a market cap or net worth of 3.96 million. The enterprise value is 4.51 million.
| Market Cap | 3.96M |
| Enterprise Value | 4.51M |
Important Dates
The next estimated earnings date is Tuesday, April 29, 2025.
| Earnings Date | Apr 29, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +160.95% |
| Shares Change (QoQ) | +47.80% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 165.58M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.43 |
| PB Ratio | 0.64 |
| P/TBV Ratio | 1.66 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -4.23 |
| EV / Sales | 0.47 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -2.06 |
Financial Position
The company has a current ratio of 1.44, with a Debt / Equity ratio of 0.19.
| Current Ratio | 1.44 |
| Quick Ratio | 0.54 |
| Debt / Equity | 0.19 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.55 |
| Interest Coverage | -23.83 |
Financial Efficiency
Return on equity (ROE) is -20.89% and return on invested capital (ROIC) is -32.07%.
| Return on Equity (ROE) | -20.89% |
| Return on Assets (ROA) | -20.94% |
| Return on Invested Capital (ROIC) | -32.07% |
| Return on Capital Employed (ROCE) | -37.53% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.99 |
| Inventory Turnover | 2.54 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -50.82% in the last 52 weeks. The beta is 2.41, so ELLXF's price volatility has been higher than the market average.
| Beta (5Y) | 2.41 |
| 52-Week Price Change | -50.82% |
| 50-Day Moving Average | 0.02 |
| 200-Day Moving Average | 0.02 |
| Relative Strength Index (RSI) | 41.80 |
| Average Volume (20 Days) | 3,960 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ELLXF had revenue of 9.26 million and -1.07 million in losses. Loss per share was -0.01.
| Revenue | 9.26M |
| Gross Profit | 3.32M |
| Operating Income | -3.13M |
| Pretax Income | -3.29M |
| Net Income | -1.07M |
| EBITDA | -2.79M |
| EBIT | -3.13M |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 667,120 in cash and 1.20 million in debt, giving a net cash position of -533,449.
| Cash & Cash Equivalents | 667,120 |
| Total Debt | 1.20M |
| Net Cash | -533,449 |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 6.20M |
| Book Value Per Share | 0.03 |
| Working Capital | 1.36M |
Cash Flow
In the last 12 months, operating cash flow was -2.15 million and capital expenditures -37,131, giving a free cash flow of -2.18 million.
| Operating Cash Flow | -2.15M |
| Capital Expenditures | -37,131 |
| Free Cash Flow | -2.18M |
| FCF Per Share | n/a |
Margins
Gross margin is 35.82%, with operating and profit margins of -33.78% and -11.51%.
| Gross Margin | 35.82% |
| Operating Margin | -33.78% |
| Pretax Margin | -35.51% |
| Profit Margin | -11.51% |
| EBITDA Margin | -30.17% |
| EBIT Margin | -33.78% |
| FCF Margin | n/a |
Dividends & Yields
ELLXF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -160.95% |
| Shareholder Yield | -160.95% |
| Earnings Yield | -26.94% |
| FCF Yield | -55.22% |
Stock Splits
The last stock split was on December 2, 2024. It was a reverse split with a ratio of 0.125.
| Last Split Date | Dec 2, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.125 |
Scores
ELLXF has an Altman Z-Score of -16.8. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -16.8 |
| Piotroski F-Score | n/a |